Loading…

A high-titer, high-thermal-amplitude autoanti-B associated with acrocyanosis but no obvious hemolytic anemia

BACKGROUND: ABO autoantibodies are rare. Most reported examples have been antibodies with 4°C titers not greater than 256 in patients without apparent hemolytic anemia. Most high‐titer, high‐thermal‐amplitude, complement‐activating cold agglutinins are associated with hemolytic anemia. STUDY DESIGN...

Full description

Saved in:
Bibliographic Details
Published in:Transfusion (Philadelphia, Pa.) Pa.), 2003-08, Vol.43 (8), p.1133-1137
Main Authors: Arndt, Patricia A., Do, Jennifer B., Garratty, George, Kuriyan, Mercy A., Strair, Roger K., Baranwal, Akhil
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND: ABO autoantibodies are rare. Most reported examples have been antibodies with 4°C titers not greater than 256 in patients without apparent hemolytic anemia. Most high‐titer, high‐thermal‐amplitude, complement‐activating cold agglutinins are associated with hemolytic anemia. STUDY DESIGN AND METHODS: A 52‐year‐old man presented with acrocyanosis and mild small‐vessel brain disease, but no evidence of obvious hemolytic anemia. Regular plasmapheresis treatment was helpful in relieving the clinical symptoms associated with acrocyanosis. Serologic methods were used to study the patient's RBCs and sera. RESULTS: The patient's RBCs were strongly reactive with anti‐C3 and anti‐IgM and weakly reactive with anti‐IgA. The patient's serum contained a high‐titer, high‐thermal‐amplitude, IgMκ autoanti‐B, capable of activating complement in vitro. CONCLUSION: A patient with a powerful ABO autoantibody is described. This patient had acrocyanosis but did not appear to have an obvious hemolytic anemia. This case is a good example of the lack of correlation between in vitro serologic tests and in vivo reactions in individual patients.
ISSN:0041-1132
1537-2995
DOI:10.1046/j.1537-2995.2003.00453.x